This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Clinical Development Remove Genetic Analysis Remove Medicine Related Topics
Genetic Disease Contamination In-Vitro Genetics Protein RNA DNA Genomics Genome Gene More Related Topics >
article thumbnail

Unlocking the potential of mRNA for the future treatment of rare diseases 

Drug Discovery World

FEBRUARY 28, 2023

Arcturus Therapeutics has one rare disease program focused on ornithine transcarbamylase deficiency in Phase II clinical study, as well as a preclinical program to investigate an mRNA medicine for cystic fibrosis. She is passionate about advancing research in the pursuit of healthier lives for all.

Genetics 52
Genetics Genetic Analysis Vaccination Vaccine 52
article thumbnail

Precision cancer therapies: Where are we?

Drug Discovery World

MARCH 2, 2023

Positive early signs for precision cancer therapies In the first presentation, Dr Fiona McLaughlin, CSO, provided an update on Avacta’s oncology candidates that are currently in clinical development. She explained the mechanism by which AVA6000 can provide more precise treatment than current chemotherapies.

Trials 52
Trials Development Genetic Analysis Drugs 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024